terry kotrla, ms, mt(ascp)bb unit 1 part 6 hypersensitivity reactions

41
Terry Kotrla, MS, MT(ASCP)BB Unit 1 Part 6 Hypersensitivity Reactions

Upload: margery-tate

Post on 25-Dec-2015

217 views

Category:

Documents


0 download

TRANSCRIPT

Terry Kotrla, MS, MT(ASCP)BB

Unit 1 Part 6Hypersensitivity Reactions

Hypersensitivity ReactionsWhen the immune system "goes wrong" .

Immune response should be protective.In this process damage to host occurs.

Hypersensitivity denotes a state of increased reactivity of the host to an antigen and implies that the reaction is damaging to the host.The individual must first have become sensitized by

previous exposure to the antigen.On second and subsequent exposures, symptoms and

signs of a hypersensitivity state occur.

Hypersensitivity ReactionsImmediate hypersensitivity refers to

antibody mediated reactions – symptoms develop within minutes to hours

Delayed hypersensitivity refers to cell mediated immunity, symptoms not observed for 24 to 48 hours.

Four ClassificationsType I (Immediate) HypersensitivityType II (cytotoxic) hypersensitivityType III (immune complex mediated)

hypersensitivityType IV (delayed) hypersensitivity

Type I (Immediate) HypersensitivityDistinguishing feature short lag time.Key reactant is IgEAntigens which trigger response called atopic

antigens or allergens.Atopy – inherited tendency to immunologically

respond to inhaled or ingested allergens with increased IgE production.

Type I (Immediate) HypersensitivityIgE primarily synthesized in lymphoid tissue

of respiratory and GI tract.Regulated by T helper cells.Specific interleukins are involved in

development of eosinophils and promote development of mast cells.

All act to stimulate overproduction of mucus.

Basophils and mast cells have highest number of receptors for Fc portion of IgE on surface.

Type I (Immediate) HypersensitivityReactions range from mild manifestations

associated with food allergies to life-threatening anaphylactic shock.Atopic allergies include hay fever, asthma,

food allergies and eczema.Exposure to allergens can be through inhalation,

absorption from the digestive tract or direct skin contact.

Extent of allergic response related to port of entry, i.e., bee sting introduces allergen directly into the circulation.

Caused by inappropriate IgE productionThis antibody has an affinity for mast cells or

basophils.

Type I (Immediate) Hypersensitivity

Type I (Immediate) HypersensitivityWhen IgE meets its specific allergen it

causes the mast cell to discharge its contents of vasoactive substances into the circulation.

This release leads to symptoms of: sneezing, runny noses, red watery eyes and wheezing.

Symptoms subside when allergen is gone.The most common immunological

abnormality seen in medical practice, estimated that 30% of US population has allergies.

Type I (Immediate) HypersensitivityAnaphylactic shock is the most serious and

fortunately the rarest form of this Type I hypersensitivity.

Symptoms are directly related to the massive release of vasoactive substances leading to fall in blood pressure, shock, difficulty in breathing and even death.

It can be due to the following:Horse gamma globulin given to patients who are

sensitized to horse protein.Injection of a drug that is capable of acting as a

hapten into a patient who is sensitive, ie, penicillin.Following a wasp or bee sting in highly sensitive

individuals.Foods – peanuts, shellfish, etc.

Type I (Immediate) HypersensitivityAnaphylaxis

Type I (Immediate) HypersensitivityAnaphylaxis

Type I (Immediate) HypersensitivityAnaphylaxis

Type I (Immediate) HypersensitivityTreatment

Avoidance of known allergensLocalized reactions use OTC antihistamines and

decongestants.Asthma uses combination – antihistamines,

bronchodilators and corticosteroids.Systemic use epinephrineHyposensitization – inject antigen to cause

production of IgG which binds to antigen (allergen) before it reaches IgE coated cells.

Monocolonal anti-IgE – inject, binds to receptors on mast cells blocking them from the IgE.

Type I (Immediate) HypersensitivityEpipen

Type I (Immediate) HypersensitivityTesting

In-Vivo Tests - Skin testsSmall amount of allergen injected into skinLook for wheal formation of 3mm or greater

in diameterSimple, inexpensive, can screen for

multiple allergens.Stop anti-histamines 24-72 hours before

test.Danger of systemic reactionNot for children under 3

Type I (Immediate) HypersensitivityDoctors sometimes use skin tests to diagnose allergies.

Type I (Immediate) HypersensitivityThe reactions shown here demonstrate allergic

response.

Type I (Immediate) Hypersensitivity

In-Vitro TestsMeasure total IgE or antigen-specific IgELess sensitive than skin tests.RIST, RAST, Allergen specific and

Microarray will be covered later.

Type II (Cytotoxic) HypersensitivityTriggered by antigens found on cell surfaces

Altered self antigensHeteroantigens

Manifested by the production of IgG or IgM antibodies which coat the antigens.

MechanismsAntibody coats cell surface promotes phagocytosis

– macrophages, neutrophils and eosinophils have Fc receptors to bind to antibody on target cell.

Natural Kill cells have Fc receptors, bind, results in cytotoxicity

Complement Coats cells which enhances phagocytosisComplement cascade goes to completion results in cell

lysis.

Type II (Cytotoxic) HypersensitivityTransfusion reactions

Hundreds of different antigens expressed on RBCsAntibodies can be produced naturally or through

exposure, transfusion or pregnancy most commonMost well known example due to ABO

incompatibility.Individuals form potent antibodies against ABO

antigens not present on their red blood cells.Group O individuals have anti-A and if transfused

with group A blood will have an immediate, and possibly fatal, reaction

Other blood groups may cause delayed reaction or acute reactions.

Type II (Cytotoxic) HypersensitivityHemolytic disease of the fetus and newborn

Mother exposed to blood group antigens due to previous pregnancy with antigen positive child or transfusion.

Antibody must be IgGCrosses placenta and coats fetal RBCs, destruction

of RBCs causes increased bilirubin and anemia.If first pregnancy is first exposure infant usually not

affected.Subsequent pregnancies have increased risk and

the disease ranges from mild to fatal.All pregnant women are screened for blood group

antibodies.

Type II (Cytotoxic) HypersensitivityAutoimmune hemolytic anemia

Patients form antibodies to antigens on their on RBCs.Warm antibodies react at 37CCold antibodies react best in-vitro at 4C and will

dissociate at 37CThis will be discussed in detail during

Immunohematology.Drug induced hemolysis

Some drugs may act as haptens, attach to the RBC membrane causing antibodies to be formed.

Antibody reacts with drug on RBC causing hemolysis.

Type II (Cytotoxic) HypersensitivityPeripheral Smear

Type II (Cytotoxic) HypersensitivityTests

Coomb’s or anti-human globulin test.Direct Coomb’s

Add anti-IgG to washed drop of RBCsIf cells are coated with IgG then

agglutination will occur.Indirect Coomb’s

Incubate patient serum with RBCs of known antigenic make up.

Wash and add anti-IgGIf patient has antibody against antigen on

RBC agglutination will occur.

Type II (Cytotoxic) HypersensitivitySome individuals make antibody which cross

reacts with self antigens found in both the lung and kidney.

Goodpasture syndrome most well known exampleAntibody produced against basement membrane

protein.This protein present in lungs and kidneys.Antibody binding results in inflammationSymptoms are hemoptysis and hematuria.

Others will be discussed laterHashimoto’s diseaseMyasthenia GravisDiabetes mellitus

Type II (Cytotoxic) Hypersensitivity

Type III (immune complex mediated) HypersensitivitySimilar to Type II, IgG or IgM involved and

destruction is complement mediated.Difference is that antigen is SOLUBLE.Soluble antigen and antibody combine to form

complexes.Usually complexes cause no symptoms, quickly

disappear from the circulation.Size of complexes produced seems important

in determining whether they will be eliminated quickly from the body or retained long enough to cause damage.

In some individuals the immune complexes persist in circulation causing clinical symptoms, some of them serious.

Type III (immune complex mediated) HypersensitivityMechanism

Soluble immune complexes which contain a greater proportion of antigen than antibody penetrate blood vessels and lodge on the basement membrane

At the basement membrane site, these complexes activate the complement cascade.

During complement activation, certain products of the cascade are produced,`attract neutrophils to the area. Such substances are known as chemotactic substances.

Once the polymorphs reach the basement membrane they release their granules, which contain lysosomal enzymes which are damaging to the blood vessel.

This total process leads to the condition recognized histologically as vasculitis.

Type III (immune complex mediated) Hypersensitivity

Type III (immune complex mediated) HypersensitivityTissues most frequently affected are:

Glomerular basementVascular endotheliumJoint liningsPulmonary alveolar membranes

Classical clinical symptoms of immune complex disease are due to blood vessel involvement, i.e., vasculitis.

Blood vessels of joints and the kidney are most frequently affected, giving rise to symptoms of arthritis and glomerulonephritis.

Type III (immune complex mediated) Hypersensitivity Arthus Reaction

Immunized rabbits to antigen Rabbits then injected intradermally with antigen Localized inflammatory reaction occurred followed by hemorrhagic

necrotic lesion. Occurred due to immune complexes depositing in dermal blood

vessels. Complement, neutrophils and platelets caused toxic affects. Rare in humans.

Serum Sickness Due to passive immunization with animal serum, bovine or horse. Vaccines and bee stings may also trigger. Symptoms appear 7 – 21 days after exposure to animal serum. Headache, fever, nausea, vomiting, joint pain, rashes and

lymphadenopathy. Symptoms due to antibody being formed at same time antigen is

present = immune complexes form. Benign, self limiting, 7-30 days for recovery.

Type III (immune complex mediated) HypersensitivityChronic immune complex diseases are

naturally occurring diseases caused by deposits of immune complex and complement in the tissues.Systemic Lupus Erythematosus (SLE)Acute glomerulonephritisRheumatic feverRheumatoid arthritis

Type IV (delayed) HypersensitivityUsed to describe the signs and symptoms

associated with a cell mediated immune response.

Results from reactions involving T lymphocytes.

Characteristics of this phenomenon are:Delayed, taking 12 hours to develop.Causes accumulation of lymphs and

macrophages.Reaction is not mediated by histamine.Antibodies are not involved in the

reaction.

Type IV (delayed) HypersensitivityMost well known is the Koch

PhenomenonInject tuberculoprotein (PPD test)

intradermally Reaction results in an area of induration of 5

mm or more in diameter and surrounded by erythema

Reaction which occurs within 48 hours is a positive.

Type IV (delayed) HypersensitivityPositive TB Test

Type IV (delayed) HypersensitivityContact dermatitis due to contact with chemicals

Poison ivy, oak and sumac give off urushiol.Nickel, rubber, formaldehyde, hair dyes,

comseticsLatex allergies Function as haptensCauses erythema, swelling and formation of

papulesHypersensitivity Pneumonitis

Response of sensitized T cells to inhaled allergens.

Caused by chronic inhalation of microorganisms.Occupationally related – pigeons, farmers

Type IV (delayed) Hypersensitivity

Type IV (delayed) Hypersensitivity

Summary

Referenceshttp://www.thebody.com/nih/immune_system.h

tmlhttp://pathmicro.med.sc.edu/ghaffar/hyper00.h

tmhttp://home.kku.ac.th/acamed/kanchana/bsi.ht

ml